FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Undergoing review to produce its tissue grafts locally at its Kunshan plant in China. Also seen: Late clinical · capacity

  • Applied for approval to produce MegaDerm Plus locally in China. Source

Roles often seen at this stageRegulatory affairs · Manufacturing & MSAT · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

L&C Bio

A maker of human-tissue grafts such as acellular dermal matrix and aesthetic products, preparing local production at its Kunshan plant in China.

Progress reported

Its Chinese subsidiary applied for approval to produce MegaDerm Plus locally.

Official role guide

L&C Bio careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 엘앤씨바이오, 메가덤플러스 中 현지생산 허가심사 개시…연내 양산 추진 ↗다음 뉴스 · Published 2026-03-04 · Sources checked 2026-11-15 · Original unavailable
  2. 엘앤씨바이오, 中 '메가덤플러스' 현지 생산허가 추진…쿤산공장 양산 본격화 ↗이투데이 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable